Product Information
OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1195 per EA under NDC 31722094905. Its NADAC has been published 337 times since Mar 11, 2020.
FDA first approved this application on Mar 22, 2017. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the Oxycodone and Acetaminophen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
325; 5 mg/1; mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722094905
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207419FDA Approved
3/22/2017
TE Code
AA
On Market Since
4/11/2017
Pharmacological Classes
Price Statistics
The NADAC for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET has been published 337 times since Mar 11, 2020, and over the history we have for it it has risen 40.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1195 per EA |
|---|---|
| All-time high | $0.1339 (Apr 16, 2025) |
| All-time low | $0.0776 (May 20, 2020) |
| 52-week high | $0.1230 |
| 52-week low | $0.1178 |
| Median price | $0.1034 |
| Average price | $0.1042 |
| Largest weekly change | +13.9% (Feb 22, 2023) |
| Weeks tracked | 337 |
| Tracking since | Mar 11, 2020 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.1195 per EA (NDC 31722094905), effective Aug 19, 2026.
How has the price of OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET has risen 40.4%. It has been tracked across 337 weekly CMS publications since Mar 11, 2020.
What are the highest and lowest recorded NADAC prices for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET?
Since Mar 11, 2020, the NADAC for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET has ranged from a low of $0.0776 (May 20, 2020) to a high of $0.1339 (Apr 16, 2025), with a median of $0.1034 per EA.
Are there cheaper alternatives to OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET, is $0.0864 per EA — about 28% below OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET.
Who manufactures OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET?
OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET (NDC 31722094905) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.